fanta.bio Sample: CNhs11769
23288 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| CHD8 SRX1683031 | Brain Neural | 3217 / 30141 (10.7%) | 70 / 20477 (0.3%) | −324.0 | −324.0 | 31.22 |
| SETD1A SRX4046309 | Erythroblasts Blood | 2039 / 30141 (6.8%) | 46 / 20477 (0.2%) | −324.0 | −324.0 | 30.11 |
| HCFC1 SRX092569 | HeLa Uterus | 2610 / 30141 (8.7%) | 60 / 20477 (0.3%) | −324.0 | −324.0 | 29.55 |
| CREB1 SRX6780853 | Frontal cortex Neural | 1910 / 30141 (6.3%) | 47 / 20477 (0.2%) | −324.0 | −324.0 | 27.61 |
| KDM5B SRX055304 | U-937 Blood | 2766 / 30141 (9.2%) | 69 / 20477 (0.3%) | −324.0 | −324.0 | 27.23 |
| O-GlcNAc SRX7141990 | Adipocytes Adipocyte | 2725 / 30141 (9.0%) | 69 / 20477 (0.3%) | −324.0 | −324.0 | 26.83 |
| NELFB SRX19246523 | SYO-1 Others | 6460 / 30141 (21.4%) | 166 / 20477 (0.8%) | −324.0 | −324.0 | 26.44 |
| NELFCD SRX19246525 | SYO-1 Others | 6679 / 30141 (22.2%) | 173 / 20477 (0.8%) | −324.0 | −324.0 | 26.23 |
| YY1 SRX092576 | HeLa Uterus | 2005 / 30141 (6.7%) | 52 / 20477 (0.3%) | −324.0 | −324.0 | 26.20 |
| NELFE SRX19888697 | BT-549 Breast | 3155 / 30141 (10.5%) | 84 / 20477 (0.4%) | −324.0 | −324.0 | 25.52 |
| O-GlcNAc SRX7141992 | Adipocytes Adipocyte | 3157 / 30141 (10.5%) | 86 / 20477 (0.4%) | −324.0 | −324.0 | 24.94 |
| SIN3B SRX17989901 | MDA-MB-231 Breast | 2089 / 30141 (6.9%) | 57 / 20477 (0.3%) | −324.0 | −324.0 | 24.90 |
| GABPA SRX644408 | DU 145 Prostate | 2232 / 30141 (7.4%) | 61 / 20477 (0.3%) | −324.0 | −324.0 | 24.86 |
| O-GlcNAc SRX7141991 | Adipocytes Adipocyte | 3496 / 30141 (11.6%) | 98 / 20477 (0.5%) | −324.0 | −324.0 | 24.24 |
| KDM5B SRX055308 | MCF-7 Breast | 2919 / 30141 (9.7%) | 82 / 20477 (0.4%) | −324.0 | −324.0 | 24.18 |
| NELFCD SRX19246543 | SYO-1 Others | 7258 / 30141 (24.1%) | 205 / 20477 (1.0%) | −324.0 | −324.0 | 24.05 |
| NELFA SRX19246522 | SYO-1 Others | 7861 / 30141 (26.1%) | 227 / 20477 (1.1%) | −324.0 | −324.0 | 23.53 |
| HCFC1 SRX092568 | HeLa Uterus | 3856 / 30141 (12.8%) | 112 / 20477 (0.5%) | −324.0 | −324.0 | 23.39 |
| GABPA SRX3321935 | MCF-7 Breast | 2258 / 30141 (7.5%) | 66 / 20477 (0.3%) | −324.0 | −324.0 | 23.24 |
| GMEB2 SRX2636259 | Hep G2 Liver | 2645 / 30141 (8.8%) | 79 / 20477 (0.4%) | −324.0 | −324.0 | 22.75 |
| MYBBP1A SRX8171744 | BJ Epidermis | 2892 / 30141 (9.6%) | 87 / 20477 (0.4%) | −324.0 | −324.0 | 22.58 |
| CDK7 SRX668243 | Jurkat Blood | 3190 / 30141 (10.6%) | 97 / 20477 (0.5%) | −324.0 | −324.0 | 22.34 |
| GTF2B SRX11196943 | 293 Kidney | 4148 / 30141 (13.8%) | 129 / 20477 (0.6%) | −324.0 | −324.0 | 21.85 |
| Epitope tags SRX16749718 | SYO-1 Others | 4822 / 30141 (16.0%) | 155 / 20477 (0.8%) | −324.0 | −324.0 | 21.14 |
| SIN3B SRX17989902 | MDA-MB-231 Breast | 1857 / 30141 (6.2%) | 60 / 20477 (0.3%) | −324.0 | −324.0 | 21.03 |
| NELFA SRX19246541 | SYO-1 Others | 9579 / 30141 (31.8%) | 313 / 20477 (1.5%) | −324.0 | −324.0 | 20.79 |
| PBRM1 SRX14999326 | 786-O Kidney | 1863 / 30141 (6.2%) | 61 / 20477 (0.3%) | −324.0 | −324.0 | 20.75 |
| GMEB2 SRX2636258 | Hep G2 Liver | 2126 / 30141 (7.1%) | 70 / 20477 (0.3%) | −324.0 | −324.0 | 20.63 |
| BAP1 SRX10045340 | CAL-51 Breast | 2060 / 30141 (6.8%) | 69 / 20477 (0.3%) | −324.0 | −324.0 | 20.28 |
| YY2 SRX1530266 | HeLa Uterus | 2442 / 30141 (8.1%) | 82 / 20477 (0.4%) | −324.0 | −324.0 | 20.23 |
| MYBBP1A SRX8171732 | PANC-1 Pancreas | 4097 / 30141 (13.6%) | 138 / 20477 (0.7%) | −324.0 | −324.0 | 20.17 |
| CHD8 SRX1683033 | iPSC derived neural cells Pluripotent stem cell | 3611 / 30141 (12.0%) | 124 / 20477 (0.6%) | −324.0 | −324.0 | 19.78 |
| REL SRX10145208 | CD4+ T cells Blood | 2872 / 30141 (9.5%) | 99 / 20477 (0.5%) | −324.0 | −324.0 | 19.71 |
| SUPT5H SRX6435410 | 293 Kidney | 5047 / 30141 (16.7%) | 174 / 20477 (0.8%) | −324.0 | −324.0 | 19.71 |
| NELFA SRX3852897 | K-562 Blood | 5909 / 30141 (19.6%) | 209 / 20477 (1.0%) | −324.0 | −324.0 | 19.21 |
| NELFE SRX1758506 | MCF-7 Breast | 3957 / 30141 (13.1%) | 140 / 20477 (0.7%) | −324.0 | −324.0 | 19.20 |
| NELFCD SRX7677725 | DLD-1 Digestive tract | 1865 / 30141 (6.2%) | 66 / 20477 (0.3%) | −324.0 | −324.0 | 19.20 |
| ASXL1 SRX10045331 | CAL-51 Breast | 2117 / 30141 (7.0%) | 75 / 20477 (0.4%) | −324.0 | −324.0 | 19.18 |
| CREB1 SRX10119153 | MV-4-11 Blood | 3241 / 30141 (10.8%) | 115 / 20477 (0.6%) | −324.0 | −324.0 | 19.15 |
| CREB1 SRX10119155 | MV-4-11 Blood | 3175 / 30141 (10.5%) | 114 / 20477 (0.6%) | −324.0 | −324.0 | 18.92 |
| HCFC1 SRX2424045 | GM12878 Blood | 4888 / 30141 (16.2%) | 177 / 20477 (0.9%) | −324.0 | −324.0 | 18.76 |
| NELFE SRX2378771 | U2OS Bone | 4803 / 30141 (15.9%) | 175 / 20477 (0.9%) | −324.0 | −324.0 | 18.65 |
| O-GlcNAc SRX7141987 | Adipocytes Adipocyte | 5735 / 30141 (19.0%) | 209 / 20477 (1.0%) | −324.0 | −324.0 | 18.64 |
| KAT2A SRX5930124 | Acute myeloid leukemia Blood | 1993 / 30141 (6.6%) | 73 / 20477 (0.4%) | −324.0 | −324.0 | 18.55 |
| CREB1 SRX10119154 | MV-4-11 Blood | 3354 / 30141 (11.1%) | 123 / 20477 (0.6%) | −324.0 | −324.0 | 18.53 |
| NELFE SRX1758495 | MCF-7 Breast | 5860 / 30141 (19.4%) | 215 / 20477 (1.0%) | −324.0 | −324.0 | 18.52 |
| YY1 SRX2778390 | Lymphoblastoid cell line Blood | 2124 / 30141 (7.0%) | 78 / 20477 (0.4%) | −324.0 | −324.0 | 18.50 |
| HCFC1 SRX2424078 | Hep G2 Liver | 2576 / 30141 (8.5%) | 95 / 20477 (0.5%) | −324.0 | −324.0 | 18.42 |
| NELFE SRX1758507 | MCF-7 Breast | 5251 / 30141 (17.4%) | 195 / 20477 (1.0%) | −324.0 | −324.0 | 18.29 |
| ASXL1 SRX10045338 | CAL-51 Breast | 2531 / 30141 (8.4%) | 94 / 20477 (0.5%) | −324.0 | −324.0 | 18.29 |
| CREB1 SRX6780868 | iPSC derived neural cells Pluripotent stem cell | 3134 / 30141 (10.4%) | 117 / 20477 (0.6%) | −324.0 | −324.0 | 18.20 |
| NELFE SRX19888696 | BT-549 Breast | 7218 / 30141 (23.9%) | 270 / 20477 (1.3%) | −324.0 | −324.0 | 18.16 |
| TP53BP1 SRX4727912 | hESC H9 Pluripotent stem cell | 3390 / 30141 (11.2%) | 127 / 20477 (0.6%) | −324.0 | −324.0 | 18.13 |
| SUPT5H SRX6435392 | 293 Kidney | 4779 / 30141 (15.9%) | 180 / 20477 (0.9%) | −324.0 | −324.0 | 18.04 |
| MYBBP1A SRX8171731 | PANC-1 Pancreas | 4509 / 30141 (15.0%) | 170 / 20477 (0.8%) | −324.0 | −324.0 | 18.02 |
| PBRM1 SRX15419284 | NCC010 Kidney | 2068 / 30141 (6.9%) | 78 / 20477 (0.4%) | −324.0 | −324.0 | 18.01 |
| SUPT5H SRX6435393 | 293 Kidney | 5617 / 30141 (18.6%) | 212 / 20477 (1.0%) | −324.0 | −324.0 | 18.00 |
| KDM5A SRX1721564 | T-47D Breast | 3388 / 30141 (11.2%) | 128 / 20477 (0.6%) | −324.0 | −324.0 | 17.98 |
| CREB1 SRX6780891 | iPSC derived neural cells Pluripotent stem cell | 3728 / 30141 (12.4%) | 141 / 20477 (0.7%) | −324.0 | −324.0 | 17.96 |
| CREB1 SRX10119145 | MV-4-11 Blood | 1875 / 30141 (6.2%) | 71 / 20477 (0.3%) | −324.0 | −324.0 | 17.94 |
| SP1 SRX10913943 | Dermal fibroblast Epidermis | 2796 / 30141 (9.3%) | 106 / 20477 (0.5%) | −324.0 | −324.0 | 17.92 |
| CREB1 SRX1427526 | KG-1 Blood | 1896 / 30141 (6.3%) | 72 / 20477 (0.4%) | −324.0 | −324.0 | 17.89 |
| ASXL1 SRX10045337 | CAL-51 Breast | 3130 / 30141 (10.4%) | 119 / 20477 (0.6%) | −324.0 | −324.0 | 17.87 |
| CXXC1 SRX25152586 | CD4+ T cells Blood | 2838 / 30141 (9.4%) | 108 / 20477 (0.5%) | −324.0 | −324.0 | 17.85 |
| ATF2 SRX17424633 | AGS Digestive tract | 1917 / 30141 (6.4%) | 73 / 20477 (0.4%) | −324.0 | −324.0 | 17.84 |
| MINA SRX16028852 | MDA-MB-231 Breast | 2806 / 30141 (9.3%) | 107 / 20477 (0.5%) | −324.0 | −324.0 | 17.82 |
| PBRM1 SRX8566570 | NCC010 Kidney | 2066 / 30141 (6.9%) | 79 / 20477 (0.4%) | −324.0 | −324.0 | 17.77 |
| NELFE SRX1758480 | MCF-7 Breast | 4797 / 30141 (15.9%) | 184 / 20477 (0.9%) | −324.0 | −324.0 | 17.71 |
| KMT2A SRX4931269 | 293 Kidney | 4412 / 30141 (14.6%) | 170 / 20477 (0.8%) | −324.0 | −324.0 | 17.63 |
| NELFA SRX10333913 | DLD-1 Digestive tract | 6919 / 30141 (23.0%) | 267 / 20477 (1.3%) | −324.0 | −324.0 | 17.61 |
| NELFE SRX19888707 | MCF-7 Breast | 2562 / 30141 (8.5%) | 99 / 20477 (0.5%) | −324.0 | −324.0 | 17.58 |
| NELFE SRX6066510 | HCT 116 Digestive tract | 5357 / 30141 (17.8%) | 208 / 20477 (1.0%) | −324.0 | −324.0 | 17.50 |
| REL SRX10145215 | Unclassified Unclassified | 7846 / 30141 (26.0%) | 305 / 20477 (1.5%) | −324.0 | −324.0 | 17.48 |
| YY1 SRX2778391 | Lymphoblastoid cell line Blood | 2751 / 30141 (9.1%) | 107 / 20477 (0.5%) | −324.0 | −324.0 | 17.47 |
| KMT2D SRX976241 | B cells Blood | 3312 / 30141 (11.0%) | 129 / 20477 (0.6%) | −324.0 | −324.0 | 17.44 |
| YY1 SRX3164108 | Jurkat Blood | 2807 / 30141 (9.3%) | 110 / 20477 (0.5%) | −324.0 | −324.0 | 17.34 |
| YY1 SRX2778396 | Lymphoblastoid cell line Blood | 2524 / 30141 (8.4%) | 99 / 20477 (0.5%) | −324.0 | −324.0 | 17.32 |
| GFP SRX17864036 | 293 Kidney | 2847 / 30141 (9.4%) | 112 / 20477 (0.5%) | −324.0 | −324.0 | 17.27 |
| TOP2B SRX9318379 | Glioma Neural | 3609 / 30141 (12.0%) | 142 / 20477 (0.7%) | −324.0 | −324.0 | 17.27 |
| RUNX1 SRX3789540 | Acute myeloid leukemia Blood | 5270 / 30141 (17.5%) | 208 / 20477 (1.0%) | −324.0 | −324.0 | 17.21 |
| MED1 SRX5471124 | LNCAP Prostate | 2341 / 30141 (7.8%) | 93 / 20477 (0.5%) | −324.0 | −324.0 | 17.10 |
| YY1 SRX8901839 | GSC23 Neural | 2709 / 30141 (9.0%) | 109 / 20477 (0.5%) | −324.0 | −324.0 | 16.88 |
| O-GlcNAc SRX7141988 | Adipocytes Adipocyte | 6427 / 30141 (21.3%) | 261 / 20477 (1.3%) | −324.0 | −324.0 | 16.73 |
| NPM1 SRX14127494 | Unclassified Unclassified | 2540 / 30141 (8.4%) | 104 / 20477 (0.5%) | −324.0 | −324.0 | 16.59 |
| NPM1 SRX14127500 | Unclassified Unclassified | 3009 / 30141 (10.0%) | 124 / 20477 (0.6%) | −324.0 | −324.0 | 16.49 |
| YY1 SRX032596 | CD4+ T cells Blood | 4504 / 30141 (14.9%) | 186 / 20477 (0.9%) | −324.0 | −324.0 | 16.45 |
| MED1 SRX1460854 | Th1 Cells Blood | 3895 / 30141 (12.9%) | 162 / 20477 (0.8%) | −324.0 | −324.0 | 16.33 |
| NELFE SRX1758505 | MCF-7 Breast | 4950 / 30141 (16.4%) | 207 / 20477 (1.0%) | −324.0 | −324.0 | 16.25 |
| KMT2D SRX18520343 | B cells Blood | 3203 / 30141 (10.6%) | 134 / 20477 (0.7%) | −324.0 | −324.0 | 16.24 |
| HCFC1 SRX2424077 | Hep G2 Liver | 4843 / 30141 (16.1%) | 203 / 20477 (1.0%) | −324.0 | −324.0 | 16.21 |
| YY1 SRX2778383 | Lymphoblastoid cell line Blood | 2308 / 30141 (7.7%) | 97 / 20477 (0.5%) | −324.0 | −324.0 | 16.16 |
| CPSF3L SRX9258677 | 293 Kidney | 3212 / 30141 (10.7%) | 137 / 20477 (0.7%) | −324.0 | −324.0 | 15.93 |
| RUNX1 SRX3789538 | Acute myeloid leukemia Blood | 6534 / 30141 (21.7%) | 279 / 20477 (1.4%) | −324.0 | −324.0 | 15.91 |
| SUPT5H SRX6435391 | 293 Kidney | 2101 / 30141 (7.0%) | 90 / 20477 (0.4%) | −324.0 | −324.0 | 15.86 |
| DDX21 SRX5501658 | A-375 Epidermis | 3918 / 30141 (13.0%) | 169 / 20477 (0.8%) | −324.0 | −324.0 | 15.75 |
| NELFB SRX19246505 | SYO-1 Others | 10045 / 30141 (33.3%) | 434 / 20477 (2.1%) | −324.0 | −324.0 | 15.72 |
| YY1 SRX2778395 | Lymphoblastoid cell line Blood | 2822 / 30141 (9.4%) | 122 / 20477 (0.6%) | −324.0 | −324.0 | 15.71 |
| SIX5 SRX100383 | GM12878 Blood | 4044 / 30141 (13.4%) | 175 / 20477 (0.9%) | −324.0 | −324.0 | 15.70 |
| SIN3B SRX3322383 | K-562 Blood | 2492 / 30141 (8.3%) | 108 / 20477 (0.5%) | −324.0 | −324.0 | 15.68 |
| NELFCD SRX10131664 | Bronchial tracheal epithelial cells Lung | 11414 / 30141 (37.9%) | 495 / 20477 (2.4%) | −324.0 | −324.0 | 15.67 |
| KLF1 SRX12151159 | CD34+ Blood | 2920 / 30141 (9.7%) | 127 / 20477 (0.6%) | −324.0 | −324.0 | 15.62 |
| MED1 SRX5471151 | LNCAP Prostate | 3354 / 30141 (11.1%) | 146 / 20477 (0.7%) | −324.0 | −324.0 | 15.61 |
| GFP SRX1457801 | HeLa Uterus | 3441 / 30141 (11.4%) | 151 / 20477 (0.7%) | −324.0 | −324.0 | 15.48 |
| NELFE SRX14101924 | MCF-7 Breast | 5790 / 30141 (19.2%) | 255 / 20477 (1.2%) | −324.0 | −324.0 | 15.43 |
| NELFE SRX19888705 | MCF-7 Breast | 4944 / 30141 (16.4%) | 218 / 20477 (1.1%) | −324.0 | −324.0 | 15.41 |
| SP1 SRX10913937 | Dermal fibroblast Epidermis | 5735 / 30141 (19.0%) | 253 / 20477 (1.2%) | −324.0 | −324.0 | 15.40 |
| SUPT5H SRX15235585 | HCT 116 Digestive tract | 4982 / 30141 (16.5%) | 220 / 20477 (1.1%) | −324.0 | −324.0 | 15.38 |
| E2F8 SRX359930 | LoVo Digestive tract | 2332 / 30141 (7.7%) | 103 / 20477 (0.5%) | −324.0 | −324.0 | 15.38 |
| REL SRX10145214 | Unclassified Unclassified | 3802 / 30141 (12.6%) | 168 / 20477 (0.8%) | −324.0 | −324.0 | 15.37 |
| O-GlcNAc SRX5316109 | PC-3 Prostate | 4053 / 30141 (13.4%) | 180 / 20477 (0.9%) | −324.0 | −324.0 | 15.30 |
| BANF1 SRX19664489 | Mesenchymal stem cells Others | 2879 / 30141 (9.6%) | 128 / 20477 (0.6%) | −324.0 | −324.0 | 15.28 |
| GTF2B SRX1136649 | HeLa Uterus | 3507 / 30141 (11.6%) | 156 / 20477 (0.8%) | −324.0 | −324.0 | 15.27 |
| CREB1 SRX1427528 | KG-1 Blood | 1978 / 30141 (6.6%) | 88 / 20477 (0.4%) | −324.0 | −324.0 | 15.27 |
| BAP1 SRX2900094 | CAL-51 Breast | 3051 / 30141 (10.1%) | 136 / 20477 (0.7%) | −324.0 | −324.0 | 15.24 |
| SUPT5H SRX2510822 | HeLa Uterus | 3711 / 30141 (12.3%) | 166 / 20477 (0.8%) | −324.0 | −324.0 | 15.19 |
| NELFB SRX11196912 | 293 Kidney | 3666 / 30141 (12.2%) | 164 / 20477 (0.8%) | −324.0 | −324.0 | 15.19 |
| KMT2A SRX4931244 | 293 Kidney | 2741 / 30141 (9.1%) | 123 / 20477 (0.6%) | −324.0 | −324.0 | 15.14 |
| GMEB2 SRX359934 | LoVo Digestive tract | 2939 / 30141 (9.8%) | 132 / 20477 (0.6%) | −324.0 | −324.0 | 15.13 |
| KDM5A SRX1721565 | T-47D Breast | 4469 / 30141 (14.8%) | 202 / 20477 (1.0%) | −324.0 | −324.0 | 15.03 |
| RELA SRX3638907 | U2OS Bone | 5793 / 30141 (19.2%) | 262 / 20477 (1.3%) | −324.0 | −324.0 | 15.02 |
| TBP SRX12567778 | Foreskin Epidermis | 6605 / 30141 (21.9%) | 299 / 20477 (1.5%) | −324.0 | −324.0 | 15.01 |
| BAP1 SRX14203257 | 293 Kidney | 3450 / 30141 (11.4%) | 157 / 20477 (0.8%) | −324.0 | −324.0 | 14.93 |
| BRD4 SRX9390934 | Colorectal cancer Digestive tract | 5608 / 30141 (18.6%) | 256 / 20477 (1.3%) | −324.0 | −324.0 | 14.88 |
| NELFCD SRX19246506 | SYO-1 Others | 10352 / 30141 (34.3%) | 473 / 20477 (2.3%) | −324.0 | −324.0 | 14.87 |
| MED1 SRX5471121 | LNCAP Prostate | 5950 / 30141 (19.7%) | 272 / 20477 (1.3%) | −324.0 | −324.0 | 14.86 |
| TBP SRX4367422 | Bronchial tracheal epithelial cells Lung | 5299 / 30141 (17.6%) | 243 / 20477 (1.2%) | −324.0 | −324.0 | 14.81 |
| SUPT5H SRX15235599 | HCT 116 Digestive tract | 3014 / 30141 (10.0%) | 139 / 20477 (0.7%) | −324.0 | −324.0 | 14.73 |
| E2F1 SRX1726518 | U-266 Blood | 2578 / 30141 (8.6%) | 119 / 20477 (0.6%) | −324.0 | −324.0 | 14.72 |
| YEATS2 SRX10478562 | Hep G2 Liver | 4278 / 30141 (14.2%) | 198 / 20477 (1.0%) | −324.0 | −324.0 | 14.68 |
| HCFC1 SRX2424046 | GM12878 Blood | 6553 / 30141 (21.7%) | 304 / 20477 (1.5%) | −324.0 | −324.0 | 14.64 |
| SUPT5H SRX6961680 | HCT 116 Digestive tract | 5194 / 30141 (17.2%) | 241 / 20477 (1.2%) | −324.0 | −324.0 | 14.64 |
| YY1 SRX2778386 | Lymphoblastoid cell line Blood | 2623 / 30141 (8.7%) | 122 / 20477 (0.6%) | −324.0 | −324.0 | 14.61 |
| POU5F1 SRX2431535 | BJ Epidermis | 4189 / 30141 (13.9%) | 195 / 20477 (1.0%) | −324.0 | −324.0 | 14.59 |
| O-GlcNAc SRX5316107 | PC-3 Prostate | 3431 / 30141 (11.4%) | 160 / 20477 (0.8%) | −324.0 | −324.0 | 14.57 |
| CREB1 SRX6780869 | iPSC derived neural cells Pluripotent stem cell | 3640 / 30141 (12.1%) | 170 / 20477 (0.8%) | −324.0 | −324.0 | 14.55 |
| STAG2 SRX21855193 | PF-382 Blood | 3015 / 30141 (10.0%) | 141 / 20477 (0.7%) | −324.0 | −324.0 | 14.53 |
| BRD2 SRX8090649 | Synoviocytes Others | 5658 / 30141 (18.8%) | 265 / 20477 (1.3%) | −324.0 | −324.0 | 14.51 |
| GMEB1 SRX10478071 | K-562 Blood | 4566 / 30141 (15.1%) | 214 / 20477 (1.0%) | −324.0 | −324.0 | 14.50 |
| NELFCD SRX7677720 | DLD-1 Digestive tract | 6610 / 30141 (21.9%) | 310 / 20477 (1.5%) | −324.0 | −324.0 | 14.49 |
| MINA SRX16028851 | MDA-MB-231 Breast | 5234 / 30141 (17.4%) | 246 / 20477 (1.2%) | −324.0 | −324.0 | 14.45 |
| CTCF SRX3322668 | Leg skin Epidermis | 2680 / 30141 (8.9%) | 127 / 20477 (0.6%) | −324.0 | −324.0 | 14.34 |
| CREB1 SRX6780867 | iPSC derived neural cells Pluripotent stem cell | 4236 / 30141 (14.1%) | 201 / 20477 (1.0%) | −324.0 | −324.0 | 14.32 |
| TBP SRX4367432 | Bronchial tracheal epithelial cells Lung | 8569 / 30141 (28.4%) | 407 / 20477 (2.0%) | −324.0 | −324.0 | 14.30 |
| PHF8 SRX12471391 | HeLa Uterus | 4988 / 30141 (16.5%) | 237 / 20477 (1.2%) | −324.0 | −324.0 | 14.30 |
| ELF4 SRX3323034 | 293 Kidney | 3008 / 30141 (10.0%) | 143 / 20477 (0.7%) | −324.0 | −324.0 | 14.29 |
| QSER1 SRX11489335 | HCT 116 Digestive tract | 3844 / 30141 (12.8%) | 183 / 20477 (0.9%) | −324.0 | −324.0 | 14.27 |
| TP53BP1 SRX3472376 | hESC derived neural cells Pluripotent stem cell | 3465 / 30141 (11.5%) | 165 / 20477 (0.8%) | −324.0 | −324.0 | 14.27 |
| NELFB SRX11196921 | 293 Kidney | 5990 / 30141 (19.9%) | 286 / 20477 (1.4%) | −324.0 | −324.0 | 14.23 |
| GMEB1 SRX10475441 | Hep G2 Liver | 5686 / 30141 (18.9%) | 272 / 20477 (1.3%) | −324.0 | −324.0 | 14.20 |
| NELFE SRX7677727 | DLD-1 Digestive tract | 7436 / 30141 (24.7%) | 356 / 20477 (1.7%) | −324.0 | −324.0 | 14.19 |
| KMT2B SRX2007818 | MCF-7 Breast | 2840 / 30141 (9.4%) | 136 / 20477 (0.7%) | −324.0 | −324.0 | 14.19 |
| ETS1 SRX644405 | DU 145 Prostate | 5796 / 30141 (19.2%) | 278 / 20477 (1.4%) | −324.0 | −324.0 | 14.16 |
| INSR SRX11600029 | Hep G2 Liver | 2168 / 30141 (7.2%) | 104 / 20477 (0.5%) | −324.0 | −324.0 | 14.16 |
| CDK7 SRX668244 | Jurkat Blood | 4519 / 30141 (15.0%) | 217 / 20477 (1.1%) | −324.0 | −324.0 | 14.15 |
| O-GlcNAc SRX7141989 | Adipocytes Adipocyte | 7282 / 30141 (24.2%) | 351 / 20477 (1.7%) | −324.0 | −324.0 | 14.09 |
| MAZ SRX7044869 | Erythroid Cells Blood | 4543 / 30141 (15.1%) | 219 / 20477 (1.1%) | −324.0 | −324.0 | 14.09 |
| CXXC1 SRX4046303 | Erythroblasts Blood | 2775 / 30141 (9.2%) | 134 / 20477 (0.7%) | −324.0 | −324.0 | 14.07 |
| YY1 SRX2778387 | Lymphoblastoid cell line Blood | 3056 / 30141 (10.1%) | 148 / 20477 (0.7%) | −324.0 | −324.0 | 14.03 |
| AFF4 SRX1460850 | Th1 Cells Blood | 5529 / 30141 (18.3%) | 268 / 20477 (1.3%) | −324.0 | −324.0 | 14.02 |
| PHF8 SRX022433 | HeLa Uterus | 4966 / 30141 (16.5%) | 241 / 20477 (1.2%) | −324.0 | −324.0 | 14.00 |
| GATA3 SRX5534866 | MCF-7 Breast | 4780 / 30141 (15.9%) | 232 / 20477 (1.1%) | −324.0 | −324.0 | 14.00 |
| NELFB SRX19246533 | SYO-1 Others | 11020 / 30141 (36.6%) | 535 / 20477 (2.6%) | −324.0 | −324.0 | 13.99 |
| TBP SRX4367442 | Bronchial tracheal epithelial cells Lung | 5118 / 30141 (17.0%) | 249 / 20477 (1.2%) | −324.0 | −324.0 | 13.96 |
| GFP SRX11070611 | Colorectal adenocarcinoma Digestive tract | 2886 / 30141 (9.6%) | 141 / 20477 (0.7%) | −324.0 | −324.0 | 13.91 |
| NELFE SRX14101909 | MCF-7 Breast | 6992 / 30141 (23.2%) | 342 / 20477 (1.7%) | −324.0 | −324.0 | 13.89 |
| CREBBP SRX10119151 | MV-4-11 Blood | 2224 / 30141 (7.4%) | 109 / 20477 (0.5%) | −324.0 | −324.0 | 13.86 |
| NELFB SRX11196911 | 293 Kidney | 8317 / 30141 (27.6%) | 408 / 20477 (2.0%) | −324.0 | −324.0 | 13.85 |
| E4F1 SRX5457575 | GM12878 Blood | 3056 / 30141 (10.1%) | 150 / 20477 (0.7%) | −324.0 | −324.0 | 13.84 |
| SP1 SRX10913948 | Dermal fibroblast Epidermis | 2872 / 30141 (9.5%) | 141 / 20477 (0.7%) | −324.0 | −324.0 | 13.84 |
| TET2 SRX6748229 | Prostate cancer Prostate | 3052 / 30141 (10.1%) | 150 / 20477 (0.7%) | −324.0 | −324.0 | 13.82 |
| KAT2A SRX5930125 | Acute myeloid leukemia Blood | 2763 / 30141 (9.2%) | 136 / 20477 (0.7%) | −324.0 | −324.0 | 13.80 |
| YY1 SRX2778393 | Lymphoblastoid cell line Blood | 2713 / 30141 (9.0%) | 134 / 20477 (0.7%) | −324.0 | −324.0 | 13.75 |
| BANF1 SRX19664488 | Mesenchymal stem cells Others | 4005 / 30141 (13.3%) | 198 / 20477 (1.0%) | −324.0 | −324.0 | 13.74 |
| E2F1 SRX11051023 | hTERT RPE-1 Neural | 4092 / 30141 (13.6%) | 203 / 20477 (1.0%) | −324.0 | −324.0 | 13.69 |
| TBL1Y SRX8073481 | DLBCL Blood | 2695 / 30141 (8.9%) | 134 / 20477 (0.7%) | −324.0 | −324.0 | 13.66 |
| NELFE SRX1758508 | MCF-7 Breast | 7170 / 30141 (23.8%) | 359 / 20477 (1.8%) | −324.0 | −324.0 | 13.57 |
| ESR1 SRX2897215 | Breast cancer cells Breast | 2292 / 30141 (7.6%) | 115 / 20477 (0.6%) | −324.0 | −324.0 | 13.54 |
| INTS13 SRX3934095 | Monocytes Blood | 6376 / 30141 (21.2%) | 321 / 20477 (1.6%) | −324.0 | −324.0 | 13.49 |
| SP1 SRX10913936 | Dermal fibroblast Epidermis | 8087 / 30141 (26.8%) | 408 / 20477 (2.0%) | −324.0 | −324.0 | 13.47 |
| ASCL1 SRX21236717 | IMR-32 Neural | 2606 / 30141 (8.6%) | 132 / 20477 (0.6%) | −324.0 | −324.0 | 13.41 |
| NELFE SRX19888704 | MCF-7 Breast | 5897 / 30141 (19.6%) | 299 / 20477 (1.5%) | −324.0 | −324.0 | 13.40 |
| BRD4 SRX103445 | CD4+ T cells Blood | 2006 / 30141 (6.7%) | 102 / 20477 (0.5%) | −324.0 | −324.0 | 13.36 |
| SUPT5H SRX15235593 | HCT 116 Digestive tract | 3958 / 30141 (13.1%) | 202 / 20477 (1.0%) | −324.0 | −324.0 | 13.31 |
| NPM1 SRX14127498 | Unclassified Unclassified | 3819 / 30141 (12.7%) | 195 / 20477 (1.0%) | −324.0 | −324.0 | 13.31 |
| NELFA SRX2510826 | HeLa Uterus | 5110 / 30141 (17.0%) | 261 / 20477 (1.3%) | −324.0 | −324.0 | 13.30 |
| BAP1 SRX10045345 | THP-1 Blood | 6632 / 30141 (22.0%) | 339 / 20477 (1.7%) | −324.0 | −324.0 | 13.29 |
| HIF1A SRX23900620 | Macrophages Blood | 2092 / 30141 (6.9%) | 107 / 20477 (0.5%) | −324.0 | −324.0 | 13.28 |
| INTS13 SRX3934096 | Monocytes Blood | 6936 / 30141 (23.0%) | 357 / 20477 (1.7%) | −324.0 | −324.0 | 13.20 |
| KMT2A SRX4931232 | 293 Kidney | 4499 / 30141 (14.9%) | 232 / 20477 (1.1%) | −324.0 | −324.0 | 13.17 |
| Epitope tags SRX17609407 | HCT 116 Digestive tract | 4372 / 30141 (14.5%) | 226 / 20477 (1.1%) | −324.0 | −324.0 | 13.14 |
| SIN3B SRX2423947 | Hep G2 Liver | 3028 / 30141 (10.0%) | 157 / 20477 (0.8%) | −324.0 | −324.0 | 13.10 |
| JUND SRX1136734 | Melanoma Epidermis | 6296 / 30141 (20.9%) | 327 / 20477 (1.6%) | −324.0 | −324.0 | 13.08 |
| CPSF3L SRX573052 | HeLa Uterus | 4235 / 30141 (14.1%) | 220 / 20477 (1.1%) | −324.0 | −324.0 | 13.08 |
| CXXC1 SRX25152598 | CD4+ T cells Blood | 5323 / 30141 (17.7%) | 277 / 20477 (1.4%) | −324.0 | −324.0 | 13.06 |
| ARID4B SRX8078714 | K-562 Blood | 2371 / 30141 (7.9%) | 124 / 20477 (0.6%) | −324.0 | −324.0 | 12.99 |
| SUPT5H SRX6435404 | 293 Kidney | 5427 / 30141 (18.0%) | 284 / 20477 (1.4%) | −324.0 | −324.0 | 12.98 |
| INTS13 SRX3934091 | Macrophages Blood | 3533 / 30141 (11.7%) | 185 / 20477 (0.9%) | −324.0 | −324.0 | 12.97 |
| CRTC1 SRX6780855 | Frontal cortex Neural | 5137 / 30141 (17.0%) | 270 / 20477 (1.3%) | −324.0 | −324.0 | 12.93 |
| PHF8 SRX20465958 | 786-O Kidney | 4316 / 30141 (14.3%) | 227 / 20477 (1.1%) | −324.0 | −324.0 | 12.92 |
| SALL4 SRX3888135 | SNU-398 Liver | 2071 / 30141 (6.9%) | 109 / 20477 (0.5%) | −324.0 | −324.0 | 12.91 |
| TET2 SRX6748228 | Prostate cancer Prostate | 2751 / 30141 (9.1%) | 145 / 20477 (0.7%) | −324.0 | −324.0 | 12.89 |
| ETS1 SRX5705804 | hESC derived cardiac cells Pluripotent stem cell | 3931 / 30141 (13.0%) | 208 / 20477 (1.0%) | −324.0 | −324.0 | 12.84 |
| TAF1 SRX11196940 | 293 Kidney | 5109 / 30141 (17.0%) | 271 / 20477 (1.3%) | −324.0 | −324.0 | 12.81 |
| INTS13 SRX20140896 | Neural progenitor cells Neural | 2582 / 30141 (8.6%) | 137 / 20477 (0.7%) | −324.0 | −324.0 | 12.80 |
| NELFE SRX1758481 | MCF-7 Breast | 7131 / 30141 (23.7%) | 380 / 20477 (1.9%) | −324.0 | −324.0 | 12.75 |
| NELFE SRX1758494 | MCF-7 Breast | 7839 / 30141 (26.0%) | 418 / 20477 (2.0%) | −324.0 | −324.0 | 12.74 |
| GABPA SRX029315 | CD34 Hematopoietic stem cells Blood | 4711 / 30141 (15.6%) | 252 / 20477 (1.2%) | −324.0 | −324.0 | 12.70 |
| TBP SRX4367441 | Bronchial tracheal epithelial cells Lung | 7775 / 30141 (25.8%) | 417 / 20477 (2.0%) | −324.0 | −324.0 | 12.67 |
| CREBBP SRX10119150 | MV-4-11 Blood | 2623 / 30141 (8.7%) | 141 / 20477 (0.7%) | −324.0 | −324.0 | 12.64 |
| GTF2B SRX150105 | IMR-90 Lung | 2474 / 30141 (8.2%) | 133 / 20477 (0.6%) | −324.0 | −324.0 | 12.64 |
| NELFA SRX19246550 | SYO-1 Others | 12201 / 30141 (40.5%) | 656 / 20477 (3.2%) | −324.0 | −324.0 | 12.64 |
| MED12 SRX1477664 | CD34 Hematopoietic stem cells Blood | 2938 / 30141 (9.7%) | 158 / 20477 (0.8%) | −324.0 | −324.0 | 12.63 |
| CPSF3L SRX13834100 | DLD-1 Digestive tract | 3451 / 30141 (11.4%) | 186 / 20477 (0.9%) | −324.0 | −324.0 | 12.60 |
| CRTC1 SRX6780876 | iPSC derived neural cells Pluripotent stem cell | 4135 / 30141 (13.7%) | 223 / 20477 (1.1%) | −324.0 | −324.0 | 12.60 |
| NELFA SRX387509 | HeLa Uterus | 2536 / 30141 (8.4%) | 137 / 20477 (0.7%) | −324.0 | −324.0 | 12.58 |
| NELFE SRX19246544 | SYO-1 Others | 13590 / 30141 (45.1%) | 736 / 20477 (3.6%) | −324.0 | −324.0 | 12.54 |
| EGR1 SRX190186 | GM12878 Blood | 3077 / 30141 (10.2%) | 167 / 20477 (0.8%) | −324.0 | −324.0 | 12.52 |
| CTCF SRX5709754 | MCF-7 Breast | 8321 / 30141 (27.6%) | 452 / 20477 (2.2%) | −324.0 | −324.0 | 12.51 |
| NR2C1 SRX3323054 | GM12878 Blood | 3935 / 30141 (13.1%) | 215 / 20477 (1.0%) | −324.0 | −324.0 | 12.43 |
| TBP SRX4367421 | Bronchial tracheal epithelial cells Lung | 2543 / 30141 (8.4%) | 139 / 20477 (0.7%) | −324.0 | −324.0 | 12.43 |
| E2F1 SRX334255 | Unclassified Unclassified | 3964 / 30141 (13.2%) | 217 / 20477 (1.1%) | −324.0 | −324.0 | 12.41 |
| ELF4 SRX3323033 | 293 Kidney | 4731 / 30141 (15.7%) | 259 / 20477 (1.3%) | −324.0 | −324.0 | 12.41 |
| NELFE SRX6066511 | HCT 116 Digestive tract | 9403 / 30141 (31.2%) | 515 / 20477 (2.5%) | −324.0 | −324.0 | 12.40 |
| PHF8 SRX20465962 | 786-O Kidney | 3664 / 30141 (12.2%) | 201 / 20477 (1.0%) | −324.0 | −324.0 | 12.38 |
| CTCF SRX5709753 | MCF-7 Breast | 8546 / 30141 (28.4%) | 469 / 20477 (2.3%) | −324.0 | −324.0 | 12.38 |
| MED1 SRX1460853 | Th1 Cells Blood | 2715 / 30141 (9.0%) | 149 / 20477 (0.7%) | −324.0 | −324.0 | 12.38 |
| GABPA SRX092575 | HeLa Uterus | 4279 / 30141 (14.2%) | 235 / 20477 (1.1%) | −324.0 | −324.0 | 12.37 |
| Epitope tags SRX11051037 | hTERT RPE-1 Neural | 3529 / 30141 (11.7%) | 194 / 20477 (0.9%) | −324.0 | −324.0 | 12.36 |
| E2F1 SRX334254 | Unclassified Unclassified | 4108 / 30141 (13.6%) | 226 / 20477 (1.1%) | −324.0 | −324.0 | 12.35 |
| SIX5 SRX100423 | K-562 Blood | 2707 / 30141 (9.0%) | 149 / 20477 (0.7%) | −324.0 | −324.0 | 12.34 |
| YY1 SRX2778382 | Lymphoblastoid cell line Blood | 3358 / 30141 (11.1%) | 185 / 20477 (0.9%) | −324.0 | −324.0 | 12.33 |
| YY1 SRX25050178 | HK-2 Kidney | 2430 / 30141 (8.1%) | 134 / 20477 (0.7%) | −324.0 | −324.0 | 12.32 |
| TBL1Y SRX8073482 | DLBCL Blood | 3093 / 30141 (10.3%) | 171 / 20477 (0.8%) | −324.0 | −324.0 | 12.29 |
| LEF1 SRX10774918 | DND-41 Blood | 2584 / 30141 (8.6%) | 143 / 20477 (0.7%) | −324.0 | −324.0 | 12.28 |
| O-GlcNAc SRX5316105 | LNCAP Prostate | 7299 / 30141 (24.2%) | 404 / 20477 (2.0%) | −324.0 | −324.0 | 12.27 |
| NELFE SRX1758496 | MCF-7 Breast | 8125 / 30141 (27.0%) | 450 / 20477 (2.2%) | −324.0 | −324.0 | 12.27 |
| NELFA SRX1013967 | HeLa Uterus | 8376 / 30141 (27.8%) | 464 / 20477 (2.3%) | −324.0 | −324.0 | 12.26 |
| O-GlcNAc SRX3881555 | LNCAP Prostate | 7502 / 30141 (24.9%) | 416 / 20477 (2.0%) | −324.0 | −324.0 | 12.25 |
| SUPT5H SRX6435407 | 293 Kidney | 8531 / 30141 (28.3%) | 474 / 20477 (2.3%) | −324.0 | −324.0 | 12.23 |
| CDK9 SRX447603 | MM.1S Blood | 3850 / 30141 (12.8%) | 214 / 20477 (1.0%) | −324.0 | −324.0 | 12.22 |
| TAF1 SRX4143074 | Kasumi-1 Blood | 2298 / 30141 (7.6%) | 128 / 20477 (0.6%) | −324.0 | −324.0 | 12.20 |
| DDX21 SRX5501660 | A-375 Epidermis | 7461 / 30141 (24.8%) | 418 / 20477 (2.0%) | −324.0 | −324.0 | 12.13 |
| SUPT5H SRX6961675 | HCT 116 Digestive tract | 7933 / 30141 (26.3%) | 445 / 20477 (2.2%) | −324.0 | −324.0 | 12.11 |
| PHF8 SRX4047134 | RKO Digestive tract | 4150 / 30141 (13.8%) | 233 / 20477 (1.1%) | −324.0 | −324.0 | 12.10 |
| YY1 SRX25050170 | ACHN Kidney | 2884 / 30141 (9.6%) | 162 / 20477 (0.8%) | −324.0 | −324.0 | 12.09 |
| FANCD2 SRX11998595 | SH-EP Neural | 2499 / 30141 (8.3%) | 141 / 20477 (0.7%) | −324.0 | −324.0 | 12.04 |
| SUMO2 SRX895429 | K-562 Blood | 3661 / 30141 (12.1%) | 207 / 20477 (1.0%) | −324.0 | −324.0 | 12.02 |
| SUPT5H SRX12813361 | 293 Kidney | 9231 / 30141 (30.6%) | 522 / 20477 (2.5%) | −324.0 | −324.0 | 12.01 |
| TAF1 SRX19662637 | T-47D Breast | 5508 / 30141 (18.3%) | 313 / 20477 (1.5%) | −324.0 | −324.0 | 11.96 |
| GMEB1 SRX10478070 | K-562 Blood | 5336 / 30141 (17.7%) | 305 / 20477 (1.5%) | −324.0 | −324.0 | 11.89 |
| SP1 SRX10913942 | Dermal fibroblast Epidermis | 9177 / 30141 (30.4%) | 525 / 20477 (2.6%) | −324.0 | −324.0 | 11.88 |
| PHF8 SRX3010070 | A549 Lung | 3212 / 30141 (10.7%) | 184 / 20477 (0.9%) | −324.0 | −324.0 | 11.86 |
| SIX5 SRX100428 | K-562 Blood | 2370 / 30141 (7.9%) | 136 / 20477 (0.7%) | −324.0 | −324.0 | 11.84 |
| NELFE SRX1758479 | MCF-7 Breast | 7751 / 30141 (25.7%) | 445 / 20477 (2.2%) | −324.0 | −324.0 | 11.83 |
| BANF1 SRX19664487 | Mesenchymal stem cells Others | 5293 / 30141 (17.6%) | 304 / 20477 (1.5%) | −324.0 | −324.0 | 11.83 |
| BRD4 SRX2009509 | SF8628 Neural | 9260 / 30141 (30.7%) | 532 / 20477 (2.6%) | −324.0 | −324.0 | 11.83 |
| E2F1 SRX1548207 | Wharton Jelly Cardiovascular | 2608 / 30141 (8.7%) | 150 / 20477 (0.7%) | −324.0 | −324.0 | 11.81 |
| KMT2A SRX5444520 | MOLM-13 Blood | 4729 / 30141 (15.7%) | 272 / 20477 (1.3%) | −324.0 | −324.0 | 11.81 |
| YY1 SRX8901838 | GSC23 Neural | 5071 / 30141 (16.8%) | 292 / 20477 (1.4%) | −324.0 | −324.0 | 11.80 |
| DDX21 SRX5501656 | A-375 Epidermis | 7390 / 30141 (24.5%) | 426 / 20477 (2.1%) | −324.0 | −324.0 | 11.79 |
| SUPT5H SRX4169276 | U2OS Bone | 3885 / 30141 (12.9%) | 224 / 20477 (1.1%) | −324.0 | −324.0 | 11.78 |
| ASCL1 SRX21236716 | IMR-32 Neural | 3188 / 30141 (10.6%) | 184 / 20477 (0.9%) | −324.0 | −324.0 | 11.77 |
| CDK9 SRX367328 | 293 Kidney | 7280 / 30141 (24.2%) | 421 / 20477 (2.1%) | −324.0 | −324.0 | 11.75 |
| BRD4 SRX2937351 | J-Lat A72 Blood | 2660 / 30141 (8.8%) | 154 / 20477 (0.8%) | −324.0 | −324.0 | 11.73 |
| E2F1 SRX334258 | Unclassified Unclassified | 3229 / 30141 (10.7%) | 187 / 20477 (0.9%) | −324.0 | −324.0 | 11.73 |
| CRTC1 SRX6780878 | iPSC derived neural cells Pluripotent stem cell | 4926 / 30141 (16.3%) | 286 / 20477 (1.4%) | −324.0 | −324.0 | 11.70 |
| PHF8 SRX4047133 | RKO Digestive tract | 7867 / 30141 (26.1%) | 457 / 20477 (2.2%) | −324.0 | −324.0 | 11.70 |
| DCP1A SRX128194 | HeLa Uterus | 5579 / 30141 (18.5%) | 325 / 20477 (1.6%) | −324.0 | −324.0 | 11.66 |
| NELFE SRX19246526 | SYO-1 Others | 13621 / 30141 (45.2%) | 794 / 20477 (3.9%) | −324.0 | −324.0 | 11.65 |
| ZBTB12 SRX10976547 | K-562 Blood | 2537 / 30141 (8.4%) | 148 / 20477 (0.7%) | −324.0 | −324.0 | 11.65 |
| NELFA SRX1013968 | HeLa Uterus | 9700 / 30141 (32.2%) | 567 / 20477 (2.8%) | −324.0 | −324.0 | 11.62 |
| BRD2 SRX366787 | MM.1S Blood | 2785 / 30141 (9.2%) | 163 / 20477 (0.8%) | −324.0 | −324.0 | 11.61 |
| Epitope tags SRX1758525 | MCF-7 Breast | 3160 / 30141 (10.5%) | 185 / 20477 (0.9%) | −324.0 | −324.0 | 11.60 |
| O-GlcNAc SRX2059878 | BJAB Blood | 9574 / 30141 (31.8%) | 561 / 20477 (2.7%) | −324.0 | −324.0 | 11.59 |
| SUPT5H SRX6961678 | HCT 116 Digestive tract | 7758 / 30141 (25.7%) | 455 / 20477 (2.2%) | −324.0 | −324.0 | 11.58 |
| SUMO2 SRX895433 | K-562 Blood | 2165 / 30141 (7.2%) | 127 / 20477 (0.6%) | −324.0 | −324.0 | 11.58 |
| TAF1 SRX19662638 | T-47D Breast | 5999 / 30141 (19.9%) | 353 / 20477 (1.7%) | −324.0 | −324.0 | 11.55 |
| DIDO1 SRX2423550 | K-562 Blood | 2206 / 30141 (7.3%) | 130 / 20477 (0.6%) | −324.0 | −324.0 | 11.53 |
| SUZ12 SRX646126 | Erythroblasts Blood | 2935 / 30141 (9.7%) | 173 / 20477 (0.8%) | −324.0 | −324.0 | 11.53 |
| ESR1 SRX2897214 | Breast cancer cells Breast | 5460 / 30141 (18.1%) | 322 / 20477 (1.6%) | −324.0 | −324.0 | 11.52 |
| NABP2 SRX9523537 | HT-1080 Bone | 3441 / 30141 (11.4%) | 203 / 20477 (1.0%) | −324.0 | −324.0 | 11.52 |
| E2F1 SRX1497386 | RAJI Blood | 2464 / 30141 (8.2%) | 146 / 20477 (0.7%) | −324.0 | −324.0 | 11.47 |
| TBP SRX8961847 | Mesenchymal stem cells Others | 2275 / 30141 (7.5%) | 135 / 20477 (0.7%) | −324.0 | −324.0 | 11.45 |
| CREBBP SRX359410 | 293 Kidney | 4718 / 30141 (15.7%) | 280 / 20477 (1.4%) | −324.0 | −324.0 | 11.45 |
| SUPT5H SRX15235591 | HCT 116 Digestive tract | 2441 / 30141 (8.1%) | 145 / 20477 (0.7%) | −324.0 | −324.0 | 11.44 |
| NELFCD SRX19246534 | SYO-1 Others | 13048 / 30141 (43.3%) | 777 / 20477 (3.8%) | −324.0 | −324.0 | 11.41 |
| SUPT5H SRX5062476 | U2OS Bone | 6561 / 30141 (21.8%) | 391 / 20477 (1.9%) | −324.0 | −324.0 | 11.40 |
| Epitope tags SRX17609410 | HCT 116 Digestive tract | 6079 / 30141 (20.2%) | 363 / 20477 (1.8%) | −324.0 | −324.0 | 11.38 |
| NELFE SRX1758519 | MCF-7 Breast | 6041 / 30141 (20.0%) | 361 / 20477 (1.8%) | −324.0 | −324.0 | 11.37 |
| KDM1A SRX757044 | SH-SY5Y Neural | 2242 / 30141 (7.4%) | 134 / 20477 (0.7%) | −324.0 | −324.0 | 11.37 |
| Epitope tags SRX2529783 | RAJI Blood | 2423 / 30141 (8.0%) | 145 / 20477 (0.7%) | −324.0 | −324.0 | 11.35 |
| NELFE SRX1758493 | MCF-7 Breast | 8688 / 30141 (28.8%) | 520 / 20477 (2.5%) | −324.0 | −324.0 | 11.35 |
| ESR1 SRX2897218 | Breast cancer cells Breast | 5008 / 30141 (16.6%) | 300 / 20477 (1.5%) | −324.0 | −324.0 | 11.34 |
| AFF4 SRX1460849 | Th1 Cells Blood | 6716 / 30141 (22.3%) | 403 / 20477 (2.0%) | −324.0 | −324.0 | 11.32 |
| NFYA SRX8337456 | HUDEP-2 Blood | 4461 / 30141 (14.8%) | 268 / 20477 (1.3%) | −324.0 | −324.0 | 11.31 |
| SMAD5 SRX2630388 | GM12878 Blood | 2473 / 30141 (8.2%) | 149 / 20477 (0.7%) | −324.0 | −324.0 | 11.28 |
| KMT2A SRX4931260 | MCF-7 Breast | 2605 / 30141 (8.6%) | 157 / 20477 (0.8%) | −324.0 | −324.0 | 11.27 |
| BRD4 SRX8468590 | HuH-7 Liver | 2153 / 30141 (7.1%) | 130 / 20477 (0.6%) | −324.0 | −324.0 | 11.25 |
| MED1 SRX5471147 | LNCAP Prostate | 5636 / 30141 (18.7%) | 341 / 20477 (1.7%) | −324.0 | −324.0 | 11.23 |
| RUNX1 SRX3789539 | Acute myeloid leukemia Blood | 8472 / 30141 (28.1%) | 513 / 20477 (2.5%) | −324.0 | −324.0 | 11.22 |
| SUPT5H SRX12813345 | 293 Kidney | 9471 / 30141 (31.4%) | 574 / 20477 (2.8%) | −324.0 | −324.0 | 11.21 |
| SIN3A SRX17989900 | MDA-MB-231 Breast | 5674 / 30141 (18.8%) | 344 / 20477 (1.7%) | −324.0 | −324.0 | 11.21 |
| BCL11B SRX1968078 | Thymus Blood | 6248 / 30141 (20.7%) | 379 / 20477 (1.9%) | −324.0 | −324.0 | 11.20 |
| FGFR1 SRX8083087 | CAMA-1 Breast | 3608 / 30141 (12.0%) | 219 / 20477 (1.1%) | −324.0 | −324.0 | 11.19 |
| BRD4 SRX9390938 | Colorectal cancer Digestive tract | 8994 / 30141 (29.8%) | 546 / 20477 (2.7%) | −324.0 | −324.0 | 11.19 |
| BRD4 SRX13456044 | C4-2 Prostate | 2449 / 30141 (8.1%) | 149 / 20477 (0.7%) | −324.0 | −324.0 | 11.17 |
| TBP SRX265224 | ME-1 Blood | 8836 / 30141 (29.3%) | 538 / 20477 (2.6%) | −324.0 | −324.0 | 11.16 |
| TP53BP1 SRX3472374 | hESC H9 Pluripotent stem cell | 4073 / 30141 (13.5%) | 248 / 20477 (1.2%) | −324.0 | −324.0 | 11.16 |
| NOTCH1 SRX369128 | CUTLL1 Blood | 5206 / 30141 (17.3%) | 317 / 20477 (1.5%) | −324.0 | −324.0 | 11.16 |
| KMT2A SRX5668141 | OCI-AML3 Blood | 7208 / 30141 (23.9%) | 439 / 20477 (2.1%) | −324.0 | −324.0 | 11.15 |
| Epitope tags SRX1758524 | MCF-7 Breast | 4382 / 30141 (14.5%) | 267 / 20477 (1.3%) | −324.0 | −324.0 | 11.15 |
| BRD4 SRX8468593 | HuH-7 Liver | 3347 / 30141 (11.1%) | 204 / 20477 (1.0%) | −324.0 | −324.0 | 11.15 |
| MBD5 SRX16744229 | 293 Kidney | 2411 / 30141 (8.0%) | 147 / 20477 (0.7%) | −324.0 | −324.0 | 11.14 |
| G-quadruplex SRX11196888 | 293 Kidney | 6145 / 30141 (20.4%) | 375 / 20477 (1.8%) | −324.0 | −324.0 | 11.13 |
| CXXC1 SRX4046314 | Lymphoblastoid cell line Blood | 8209 / 30141 (27.2%) | 501 / 20477 (2.4%) | −324.0 | −324.0 | 11.13 |
| CXXC5 SRX6748227 | Prostate cancer Prostate | 4538 / 30141 (15.1%) | 277 / 20477 (1.4%) | −324.0 | −324.0 | 11.13 |
| NCBP1 SRX7677736 | DLD-1 Digestive tract | 12160 / 30141 (40.3%) | 744 / 20477 (3.6%) | −324.0 | −324.0 | 11.10 |
| POU2F3 SRX22541953 | NCI-H1048 Lung | 6267 / 30141 (20.8%) | 384 / 20477 (1.9%) | −324.0 | −324.0 | 11.09 |
| SUPT5H SRX4169275 | U2OS Bone | 6229 / 30141 (20.7%) | 382 / 20477 (1.9%) | −324.0 | −324.0 | 11.08 |
| SUPT5H SRX5062484 | U2OS Bone | 3454 / 30141 (11.5%) | 212 / 20477 (1.0%) | −324.0 | −324.0 | 11.07 |
| BRD4 SRX8468589 | HuH-7 Liver | 4202 / 30141 (13.9%) | 258 / 20477 (1.3%) | −324.0 | −324.0 | 11.06 |
| THAP12 SRX13007906 | K-562 Blood | 3511 / 30141 (11.6%) | 216 / 20477 (1.1%) | −324.0 | −324.0 | 11.04 |
| ERG SRX1629254 | VCaP Prostate | 2275 / 30141 (7.5%) | 140 / 20477 (0.7%) | −324.0 | −324.0 | 11.04 |
| BRD4 SRX4326271 | SK-N-BE(2) Neural | 2161 / 30141 (7.2%) | 133 / 20477 (0.6%) | −324.0 | −324.0 | 11.04 |
| NFYA SRX8337458 | HUDEP-1 Blood | 5343 / 30141 (17.7%) | 329 / 20477 (1.6%) | −324.0 | −324.0 | 11.03 |
| AFF4 SRX573033 | HeLa Uterus | 2906 / 30141 (9.6%) | 179 / 20477 (0.9%) | −324.0 | −324.0 | 11.03 |
| CXXC5 SRX6748226 | Prostate cancer Prostate | 5660 / 30141 (18.8%) | 349 / 20477 (1.7%) | −324.0 | −324.0 | 11.02 |
| CREB1 SRX6780893 | iPSC derived neural cells Pluripotent stem cell | 6988 / 30141 (23.2%) | 431 / 20477 (2.1%) | −324.0 | −324.0 | 11.02 |
| NFYA SRX8337453 | HUDEP-2 Blood | 7826 / 30141 (26.0%) | 483 / 20477 (2.4%) | −324.0 | −324.0 | 11.01 |
| ZBTB12 SRX10976548 | K-562 Blood | 2397 / 30141 (8.0%) | 148 / 20477 (0.7%) | −324.0 | −324.0 | 11.00 |
| NR2C1 SRX3323053 | GM12878 Blood | 4325 / 30141 (14.3%) | 268 / 20477 (1.3%) | −324.0 | −324.0 | 10.96 |
| ELK3 SRX670629 | HUVEC Cardiovascular | 3482 / 30141 (11.6%) | 216 / 20477 (1.1%) | −324.0 | −324.0 | 10.95 |
| EP300 SRX359406 | 293 Kidney | 2868 / 30141 (9.5%) | 178 / 20477 (0.9%) | −324.0 | −324.0 | 10.95 |
| CPSF3L SRX573067 | HeLa Uterus | 3238 / 30141 (10.7%) | 201 / 20477 (1.0%) | −324.0 | −324.0 | 10.94 |
| INTS13 SRX20140897 | Neural progenitor cells Neural | 7726 / 30141 (25.6%) | 480 / 20477 (2.3%) | −324.0 | −324.0 | 10.94 |
| KDM6A SRX2900156 | CAL-51 Breast | 2137 / 30141 (7.1%) | 133 / 20477 (0.6%) | −324.0 | −324.0 | 10.92 |
| NFYA SRX8337457 | HUDEP-2 Blood | 5300 / 30141 (17.6%) | 330 / 20477 (1.6%) | −324.0 | −324.0 | 10.91 |
| REST SRX7627562 | Hippocampus Neural | 5587 / 30141 (18.5%) | 348 / 20477 (1.7%) | −324.0 | −324.0 | 10.91 |
| MAFB SRX13991433 | MCF 10A Breast | 4101 / 30141 (13.6%) | 256 / 20477 (1.3%) | −324.0 | −324.0 | 10.88 |
| REL SRX10145216 | Unclassified Unclassified | 11048 / 30141 (36.7%) | 691 / 20477 (3.4%) | −324.0 | −324.0 | 10.86 |
| GABPA SRX100401 | GM12878 Blood | 5993 / 30141 (19.9%) | 375 / 20477 (1.8%) | −324.0 | −324.0 | 10.86 |
| BRD4 SRX4417525 | hESC derived neural cells Pluripotent stem cell | 7395 / 30141 (24.5%) | 463 / 20477 (2.3%) | −324.0 | −324.0 | 10.85 |
| BRD4 SRX4417524 | hESC derived neural cells Pluripotent stem cell | 6930 / 30141 (23.0%) | 434 / 20477 (2.1%) | −324.0 | −324.0 | 10.85 |
| RBPJ SRX369129 | CUTLL1 Blood | 3736 / 30141 (12.4%) | 234 / 20477 (1.1%) | −324.0 | −324.0 | 10.85 |
| MYC SRX19186213 | HeLa Uterus | 5539 / 30141 (18.4%) | 347 / 20477 (1.7%) | −324.0 | −324.0 | 10.84 |
| SIN3B SRX3322382 | K-562 Blood | 5455 / 30141 (18.1%) | 342 / 20477 (1.7%) | −324.0 | −324.0 | 10.84 |
| KMT2A SRX5668135 | IMS-M2 Blood | 6300 / 30141 (20.9%) | 397 / 20477 (1.9%) | −324.0 | −324.0 | 10.78 |
| NCBP1 SRX7677738 | DLD-1 Digestive tract | 12171 / 30141 (40.4%) | 767 / 20477 (3.7%) | −324.0 | −324.0 | 10.78 |
| CPSF3L SRX20140884 | iPSC derived neural cells Pluripotent stem cell | 3419 / 30141 (11.3%) | 216 / 20477 (1.1%) | −324.0 | −324.0 | 10.75 |
| ZFX SRX4824375 | 22Rv1 Prostate | 4985 / 30141 (16.5%) | 315 / 20477 (1.5%) | −324.0 | −324.0 | 10.75 |
| BRD4 SRX8468591 | HuH-7 Liver | 2500 / 30141 (8.3%) | 158 / 20477 (0.8%) | −324.0 | −324.0 | 10.75 |
| YY1 SRX2778384 | Lymphoblastoid cell line Blood | 3242 / 30141 (10.8%) | 205 / 20477 (1.0%) | −324.0 | −324.0 | 10.74 |
| BRD4 SRX13456039 | C4-2 Prostate | 4458 / 30141 (14.8%) | 282 / 20477 (1.4%) | −324.0 | −324.0 | 10.74 |
| HCFC1 SRX2424330 | MCF-7 Breast | 5180 / 30141 (17.2%) | 328 / 20477 (1.6%) | −324.0 | −324.0 | 10.73 |
| LEF1 SRX10774917 | DND-41 Blood | 7399 / 30141 (24.5%) | 469 / 20477 (2.3%) | −324.0 | −324.0 | 10.72 |
| TOP2B SRX9318376 | Glioma Neural | 2531 / 30141 (8.4%) | 161 / 20477 (0.8%) | −324.0 | −324.0 | 10.68 |
| Epitope tags SRX11051043 | hTERT RPE-1 Neural | 2386 / 30141 (7.9%) | 152 / 20477 (0.7%) | −324.0 | −324.0 | 10.66 |
| BRD4 SRX13456043 | C4-2 Prostate | 2564 / 30141 (8.5%) | 164 / 20477 (0.8%) | −324.0 | −324.0 | 10.62 |
| NELFE SRX6066513 | HCT 116 Digestive tract | 11496 / 30141 (38.1%) | 736 / 20477 (3.6%) | −324.0 | −324.0 | 10.61 |
| NELFE SRX3852899 | K-562 Blood | 11969 / 30141 (39.7%) | 767 / 20477 (3.7%) | −324.0 | −324.0 | 10.60 |
| BRD4 SRX24117842 | HCT 116 Digestive tract | 7377 / 30141 (24.5%) | 473 / 20477 (2.3%) | −324.0 | −324.0 | 10.60 |
| SUPT5H SRX12813324 | 293 Kidney | 10740 / 30141 (35.6%) | 689 / 20477 (3.4%) | −324.0 | −324.0 | 10.59 |
| KMT2A SRX5444519 | MOLM-13 Blood | 3148 / 30141 (10.4%) | 202 / 20477 (1.0%) | −324.0 | −324.0 | 10.59 |
| KMT2A SRX14030487 | MV-4-11 Blood | 6497 / 30141 (21.6%) | 417 / 20477 (2.0%) | −324.0 | −324.0 | 10.58 |
| KDM5A SRX10476599 | Hep G2 Liver | 2723 / 30141 (9.0%) | 175 / 20477 (0.9%) | −324.0 | −324.0 | 10.57 |
| NRF1 SRX150715 | HeLa Uterus | 2167 / 30141 (7.2%) | 140 / 20477 (0.7%) | −324.0 | −324.0 | 10.52 |
| KMT2A SRX14030488 | MV-4-11 Blood | 6965 / 30141 (23.1%) | 450 / 20477 (2.2%) | −324.0 | −324.0 | 10.52 |
| GTF2B SRX1136632 | HeLa Uterus | 11623 / 30141 (38.6%) | 751 / 20477 (3.7%) | −324.0 | −324.0 | 10.51 |
| E2F1 SRX334259 | Unclassified Unclassified | 5182 / 30141 (17.2%) | 335 / 20477 (1.6%) | −324.0 | −324.0 | 10.51 |
| TP53BP1 SRX3472380 | hESC derived neural cells Pluripotent stem cell | 7869 / 30141 (26.1%) | 509 / 20477 (2.5%) | −324.0 | −324.0 | 10.50 |
| ZBTB40 SRX2423583 | GM12878 Blood | 3400 / 30141 (11.3%) | 220 / 20477 (1.1%) | −324.0 | −324.0 | 10.50 |
| IKZF1 SRX7280995 | JM1 Blood | 4528 / 30141 (15.0%) | 293 / 20477 (1.4%) | −324.0 | −324.0 | 10.50 |
| NELFE SRX6066512 | HCT 116 Digestive tract | 10907 / 30141 (36.2%) | 707 / 20477 (3.5%) | −324.0 | −324.0 | 10.48 |
| JDP2 SRX4179992 | Loucy Blood | 2175 / 30141 (7.2%) | 141 / 20477 (0.7%) | −324.0 | −324.0 | 10.48 |
| BRD4 SRX8272938 | BLaER1 Blood | 2733 / 30141 (9.1%) | 178 / 20477 (0.9%) | −324.0 | −324.0 | 10.43 |
| NEUROD1 SRX2436057 | D341 Med Neural | 7353 / 30141 (24.4%) | 479 / 20477 (2.3%) | −324.0 | −324.0 | 10.43 |
| MYCN SRX1690222 | Neuroblastoma Neural | 2838 / 30141 (9.4%) | 185 / 20477 (0.9%) | −324.0 | −324.0 | 10.42 |
| MYC SRX21164692 | EndoC-H1 Pancreas | 2376 / 30141 (7.9%) | 155 / 20477 (0.8%) | −324.0 | −324.0 | 10.41 |
| NCOR1 SRX118012 | 293 Kidney | 3109 / 30141 (10.3%) | 203 / 20477 (1.0%) | −324.0 | −324.0 | 10.40 |
| BCL11B SRX1968074 | Thymus Blood | 2951 / 30141 (9.8%) | 193 / 20477 (0.9%) | −324.0 | −324.0 | 10.39 |
| NFYC SRX359946 | LoVo Digestive tract | 4309 / 30141 (14.3%) | 282 / 20477 (1.4%) | −324.0 | −324.0 | 10.38 |
| ESR1 SRX2897216 | Breast cancer cells Breast | 7987 / 30141 (26.5%) | 524 / 20477 (2.6%) | −324.0 | −324.0 | 10.36 |
| E2F1 SRX11051042 | hTERT RPE-1 Neural | 7008 / 30141 (23.3%) | 460 / 20477 (2.2%) | −324.0 | −324.0 | 10.35 |
| SUPT5H SRX6435405 | 293 Kidney | 9593 / 30141 (31.8%) | 630 / 20477 (3.1%) | −324.0 | −324.0 | 10.34 |
| INTS13 SRX3934089 | Jurkat Blood | 8398 / 30141 (27.9%) | 552 / 20477 (2.7%) | −324.0 | −324.0 | 10.34 |
| NELFA SRX2510827 | HeLa Uterus | 3328 / 30141 (11.0%) | 219 / 20477 (1.1%) | −324.0 | −324.0 | 10.32 |
| HSF1 SRX13845501 | PC-3M Prostate | 3844 / 30141 (12.8%) | 253 / 20477 (1.2%) | −324.0 | −324.0 | 10.32 |
| BRCA1 SRX2188672 | TC-32 Bone | 3584 / 30141 (11.9%) | 236 / 20477 (1.2%) | −324.0 | −324.0 | 10.32 |
| VDR SRX21849426 | Skeletal muscle Muscle | 6058 / 30141 (20.1%) | 400 / 20477 (2.0%) | −324.0 | −324.0 | 10.29 |
| ZHX2 SRX2635884 | Hep G2 Liver | 4570 / 30141 (15.2%) | 302 / 20477 (1.5%) | −324.0 | −324.0 | 10.28 |
| HSF1 SRX13845495 | PC-3M Prostate | 4156 / 30141 (13.8%) | 275 / 20477 (1.3%) | −324.0 | −324.0 | 10.27 |
| NELFA SRX2510825 | HeLa Uterus | 2629 / 30141 (8.7%) | 174 / 20477 (0.8%) | −324.0 | −324.0 | 10.26 |
| O-GlcNAc SRX3881556 | LNCAP Prostate | 8395 / 30141 (27.9%) | 557 / 20477 (2.7%) | −324.0 | −324.0 | 10.24 |
| BRD4 SRX367313 | 293 Kidney | 7434 / 30141 (24.7%) | 494 / 20477 (2.4%) | −324.0 | −324.0 | 10.22 |
| PHF8 SRX017325 | SH-SY5Y Neural | 8802 / 30141 (29.2%) | 586 / 20477 (2.9%) | −324.0 | −324.0 | 10.20 |
| TFDP1 SRX1726517 | U-266 Blood | 4415 / 30141 (14.6%) | 294 / 20477 (1.4%) | −324.0 | −324.0 | 10.20 |
| TERF1 SRX359962 | LoVo Digestive tract | 2671 / 30141 (8.9%) | 178 / 20477 (0.9%) | −324.0 | −324.0 | 10.19 |
| LIN9 SRX4213896 | MCF 10A Breast | 5504 / 30141 (18.3%) | 367 / 20477 (1.8%) | −324.0 | −324.0 | 10.19 |
| MCRS1 SRX3445802 | Hep G2 Liver | 3389 / 30141 (11.2%) | 226 / 20477 (1.1%) | −324.0 | −324.0 | 10.19 |
| GABPA SRX2635826 | Liver Liver | 3687 / 30141 (12.2%) | 246 / 20477 (1.2%) | −324.0 | −324.0 | 10.18 |
| NFYA SRX8337454 | HUDEP-1 Blood | 8321 / 30141 (27.6%) | 556 / 20477 (2.7%) | −324.0 | −324.0 | 10.17 |
| BRD4 SRX10131683 | Bronchial tracheal epithelial cells Lung | 8409 / 30141 (27.9%) | 562 / 20477 (2.7%) | −324.0 | −324.0 | 10.17 |
| SUPT5H SRX13834127 | DLD-1 Digestive tract | 9042 / 30141 (30.0%) | 605 / 20477 (3.0%) | −324.0 | −324.0 | 10.15 |
| SUPT5H SRX6961673 | HCT 116 Digestive tract | 9503 / 30141 (31.5%) | 636 / 20477 (3.1%) | −324.0 | −324.0 | 10.15 |
| BRD4 SRX3591439 | B-CLL cells Blood | 4372 / 30141 (14.5%) | 293 / 20477 (1.4%) | −324.0 | −324.0 | 10.14 |
| NONO SRX3322243 | K-562 Blood | 4830 / 30141 (16.0%) | 324 / 20477 (1.6%) | −324.0 | −324.0 | 10.13 |
| NELFE SRX1758520 | MCF-7 Breast | 7404 / 30141 (24.6%) | 497 / 20477 (2.4%) | −324.0 | −324.0 | 10.12 |
| NELFA SRX3852895 | K-562 Blood | 11351 / 30141 (37.7%) | 762 / 20477 (3.7%) | −324.0 | −324.0 | 10.12 |
| G-quadruplex SRX8108988 | Hep G2 Liver | 2427 / 30141 (8.1%) | 163 / 20477 (0.8%) | −324.0 | −324.0 | 10.12 |
| Epitope tags SRX13107366 | U2OS Bone | 3939 / 30141 (13.1%) | 265 / 20477 (1.3%) | −324.0 | −324.0 | 10.10 |
| BAP1 SRX2900095 | CAL-51 Breast | 6758 / 30141 (22.4%) | 455 / 20477 (2.2%) | −324.0 | −324.0 | 10.09 |
| MAFB SRX13991434 | MCF 10A Breast | 7549 / 30141 (25.0%) | 509 / 20477 (2.5%) | −324.0 | −324.0 | 10.08 |
| PHF2 SRX1426078 | NAMEC8 Breast | 3233 / 30141 (10.7%) | 218 / 20477 (1.1%) | −324.0 | −324.0 | 10.08 |
| BRD4 SRX7701215 | NCI-H1963 Lung | 9119 / 30141 (30.3%) | 615 / 20477 (3.0%) | −324.0 | −324.0 | 10.07 |
| YY1 SRX2778392 | Lymphoblastoid cell line Blood | 4190 / 30141 (13.9%) | 283 / 20477 (1.4%) | −324.0 | −324.0 | 10.06 |
| NPM1 SRX14127518 | OCI-AML3 Blood | 7430 / 30141 (24.7%) | 502 / 20477 (2.5%) | −324.0 | −324.0 | 10.06 |
| GTF2F1 SRX13784673 | DLD-1 Digestive tract | 3755 / 30141 (12.5%) | 254 / 20477 (1.2%) | −324.0 | −324.0 | 10.04 |
| TBP SRX10722986 | U2OS Bone | 3297 / 30141 (10.9%) | 224 / 20477 (1.1%) | −324.0 | −324.0 | 10.00 |
| E2F1 SRX275409 | OCI-LY1 Blood | 9434 / 30141 (31.3%) | 641 / 20477 (3.1%) | −324.0 | −324.0 | 10.00 |
| KDM1A SRX757045 | SH-SY5Y Neural | 2324 / 30141 (7.7%) | 158 / 20477 (0.8%) | −324.0 | −324.0 | 9.99 |
| PHF2 SRX1426074 | HMLE Breast | 5206 / 30141 (17.3%) | 355 / 20477 (1.7%) | −324.0 | −324.0 | 9.96 |
| ZNF143 SRX159127 | HeLa Uterus | 2638 / 30141 (8.8%) | 180 / 20477 (0.9%) | −324.0 | −324.0 | 9.96 |
| CPSF3L SRX5283931 | HeLa Uterus | 8945 / 30141 (29.7%) | 612 / 20477 (3.0%) | −324.0 | −324.0 | 9.93 |
| KDM1A SRX527430 | PC-3 Prostate | 9931 / 30141 (32.9%) | 680 / 20477 (3.3%) | −324.0 | −324.0 | 9.92 |
| FGFR1 SRX8246295 | MCF-7 Breast | 3621 / 30141 (12.0%) | 248 / 20477 (1.2%) | −324.0 | −324.0 | 9.92 |
| ZHX2 SRX2635885 | Hep G2 Liver | 4314 / 30141 (14.3%) | 296 / 20477 (1.4%) | −324.0 | −324.0 | 9.90 |
| CPSF3L SRX7644285 | MCF-7 Breast | 3060 / 30141 (10.2%) | 210 / 20477 (1.0%) | −324.0 | −324.0 | 9.90 |
| CPSF3L SRX20140879 | Neural progenitor cells Neural | 4791 / 30141 (15.9%) | 329 / 20477 (1.6%) | −324.0 | −324.0 | 9.89 |
| SUPT5H SRX6435390 | 293 Kidney | 10065 / 30141 (33.4%) | 692 / 20477 (3.4%) | −324.0 | −324.0 | 9.88 |
| PHIP SRX13181594 | HCT 116 Digestive tract | 3499 / 30141 (11.6%) | 241 / 20477 (1.2%) | −324.0 | −324.0 | 9.86 |
| FANCD2 SRX11998589 | SH-EP Neural | 4665 / 30141 (15.5%) | 322 / 20477 (1.6%) | −324.0 | −324.0 | 9.84 |
| GTF2F1 SRX13784677 | DLD-1 Digestive tract | 4236 / 30141 (14.1%) | 293 / 20477 (1.4%) | −324.0 | −324.0 | 9.82 |
| HIF1A SRX23900624 | Macrophages Blood | 2992 / 30141 (9.9%) | 207 / 20477 (1.0%) | −324.0 | −324.0 | 9.82 |
| INTS13 SRX20140899 | iPSC derived neural cells Pluripotent stem cell | 2312 / 30141 (7.7%) | 160 / 20477 (0.8%) | −324.0 | −324.0 | 9.82 |
| SETD1A SRX9548658 | THP-1 Blood | 2918 / 30141 (9.7%) | 202 / 20477 (1.0%) | −324.0 | −324.0 | 9.81 |
| THAP1 SRX100453 | K-562 Blood | 4116 / 30141 (13.7%) | 285 / 20477 (1.4%) | −324.0 | −324.0 | 9.81 |
| YY1 SRX25050180 | HK-2 Kidney | 7130 / 30141 (23.7%) | 494 / 20477 (2.4%) | −324.0 | −324.0 | 9.81 |
| NFATC1 SRX335070 | HUVEC Cardiovascular | 9136 / 30141 (30.3%) | 633 / 20477 (3.1%) | −324.0 | −324.0 | 9.81 |
| MEN1 SRX4046307 | Erythroblasts Blood | 10879 / 30141 (36.1%) | 754 / 20477 (3.7%) | −324.0 | −324.0 | 9.80 |
| Epitope tags SRX2683608 | 293 Kidney | 2221 / 30141 (7.4%) | 154 / 20477 (0.8%) | −324.0 | −324.0 | 9.80 |
| ESR1 SRX9221935 | Liver Liver | 2636 / 30141 (8.7%) | 183 / 20477 (0.9%) | −324.0 | −324.0 | 9.79 |
| RB1 SRX659751 | IMR-90 Lung | 2463 / 30141 (8.2%) | 171 / 20477 (0.8%) | −324.0 | −324.0 | 9.79 |
| BRD4 SRX3591433 | B-CLL cells Blood | 7848 / 30141 (26.0%) | 545 / 20477 (2.7%) | −324.0 | −324.0 | 9.78 |
| CREB1 SRX6780892 | iPSC derived neural cells Pluripotent stem cell | 7660 / 30141 (25.4%) | 532 / 20477 (2.6%) | −324.0 | −324.0 | 9.78 |
| E2F1 SRX10475075 | Hep G2 Liver | 4574 / 30141 (15.2%) | 318 / 20477 (1.6%) | −324.0 | −324.0 | 9.77 |
| ZNF639 SRX5457274 | Hep G2 Liver | 5091 / 30141 (16.9%) | 354 / 20477 (1.7%) | −324.0 | −324.0 | 9.77 |
| MED1 SRX5471120 | LNCAP Prostate | 10673 / 30141 (35.4%) | 743 / 20477 (3.6%) | −324.0 | −324.0 | 9.76 |
| FANCD2 SRX11998588 | SH-EP Neural | 6103 / 30141 (20.2%) | 425 / 20477 (2.1%) | −324.0 | −324.0 | 9.76 |
| E2F4 SRX150410 | GM12878 Blood | 2842 / 30141 (9.4%) | 198 / 20477 (1.0%) | −324.0 | −324.0 | 9.75 |
| ASXL1 SRX10045343 | THP-1 Blood | 6874 / 30141 (22.8%) | 479 / 20477 (2.3%) | −324.0 | −324.0 | 9.75 |
| NELFE SRX14101933 | MCF-7 Breast | 10432 / 30141 (34.6%) | 728 / 20477 (3.6%) | −324.0 | −324.0 | 9.74 |
| MNT SRX14117392 | 22Rv1 Prostate | 3066 / 30141 (10.2%) | 214 / 20477 (1.0%) | −324.0 | −324.0 | 9.73 |
| BRD4 SRX1460852 | Th1 Cells Blood | 9135 / 30141 (30.3%) | 638 / 20477 (3.1%) | −324.0 | −324.0 | 9.73 |
| ZFX SRX21435872 | LN-229 Neural | 4394 / 30141 (14.6%) | 307 / 20477 (1.5%) | −324.0 | −324.0 | 9.72 |
| NFYA SRX8337455 | HUDEP-2 Blood | 8663 / 30141 (28.7%) | 606 / 20477 (3.0%) | −324.0 | −324.0 | 9.71 |
| E2F4 SRX150445 | HeLa Uterus | 4316 / 30141 (14.3%) | 302 / 20477 (1.5%) | −324.0 | −324.0 | 9.71 |
| BRD4 SRX3591430 | B-CLL cells Blood | 2957 / 30141 (9.8%) | 207 / 20477 (1.0%) | −324.0 | −324.0 | 9.70 |
| ACTR5 SRX15036448 | MCF-7 Breast | 3611 / 30141 (12.0%) | 253 / 20477 (1.2%) | −324.0 | −324.0 | 9.70 |
| ETS1 SRX2636015 | iPS cells Pluripotent stem cell | 4253 / 30141 (14.1%) | 298 / 20477 (1.5%) | −324.0 | −324.0 | 9.70 |
| ETS1 SRX3033232 | OVCAR-8 Gonad | 3573 / 30141 (11.9%) | 251 / 20477 (1.2%) | −324.0 | −324.0 | 9.67 |
| NOTCH1 SRX2442441 | iPSC derived neural cells Pluripotent stem cell | 4212 / 30141 (14.0%) | 296 / 20477 (1.4%) | −324.0 | −324.0 | 9.67 |
| TCF7 SRX10774915 | DND-41 Blood | 6881 / 30141 (22.8%) | 484 / 20477 (2.4%) | −324.0 | −324.0 | 9.66 |
| SUPT5H SRX15235586 | HCT 116 Digestive tract | 2843 / 30141 (9.4%) | 200 / 20477 (1.0%) | −324.0 | −324.0 | 9.66 |
| PHIP SRX13181593 | HCT 116 Digestive tract | 3304 / 30141 (11.0%) | 233 / 20477 (1.1%) | −324.0 | −324.0 | 9.63 |
| E2F5 SRX10475718 | Hep G2 Liver | 3939 / 30141 (13.1%) | 278 / 20477 (1.4%) | −324.0 | −324.0 | 9.63 |
| BRD7 SRX18945350 | 786-O Kidney | 3994 / 30141 (13.3%) | 282 / 20477 (1.4%) | −324.0 | −324.0 | 9.62 |
| HIF1A SRX23900623 | Macrophages Blood | 3594 / 30141 (11.9%) | 254 / 20477 (1.2%) | −324.0 | −324.0 | 9.61 |
| ETV6 SRX17149152 | Monocytes Blood | 2799 / 30141 (9.3%) | 198 / 20477 (1.0%) | −324.0 | −324.0 | 9.60 |
| MYC SRX3587641 | G-401 Kidney | 2431 / 30141 (8.1%) | 172 / 20477 (0.8%) | −324.0 | −324.0 | 9.60 |
| EZH2 SRX4212570 | Peripheral blood mononuclear cells Blood | 4449 / 30141 (14.8%) | 315 / 20477 (1.5%) | −324.0 | −324.0 | 9.60 |
| NRF1 SRX3437461 | HeLa Uterus | 2768 / 30141 (9.2%) | 196 / 20477 (1.0%) | −324.0 | −324.0 | 9.59 |
| ETS1 SRX015825 | Jurkat (Clone E6-1) Blood | 7051 / 30141 (23.4%) | 500 / 20477 (2.4%) | −324.0 | −324.0 | 9.58 |
| MYC SRX129106 | NCI-H128 Lung | 3426 / 30141 (11.4%) | 243 / 20477 (1.2%) | −324.0 | −324.0 | 9.58 |
| BRD4 SRX2795371 | Akata Blood | 7307 / 30141 (24.2%) | 520 / 20477 (2.5%) | −324.0 | −324.0 | 9.55 |
| E2F1 SRX334262 | Unclassified Unclassified | 6379 / 30141 (21.2%) | 454 / 20477 (2.2%) | −324.0 | −324.0 | 9.55 |
| TP53 SRX396254 | Fibroblasts Others | 7853 / 30141 (26.1%) | 559 / 20477 (2.7%) | −324.0 | −324.0 | 9.54 |
| KMT2A SRX5668134 | IMS-M2 Blood | 9029 / 30141 (30.0%) | 643 / 20477 (3.1%) | −324.0 | −324.0 | 9.54 |
| SMAD5 SRX2630389 | GM12878 Blood | 5866 / 30141 (19.5%) | 418 / 20477 (2.0%) | −324.0 | −324.0 | 9.53 |
| RELA SRX5888986 | Head and neck squamous cell carcinoma Others | 3043 / 30141 (10.1%) | 217 / 20477 (1.1%) | −324.0 | −324.0 | 9.53 |
| BRD4 SRX20827902 | HeLa Uterus | 3463 / 30141 (11.5%) | 247 / 20477 (1.2%) | −324.0 | −324.0 | 9.52 |
| SIN3A SRX17989899 | MDA-MB-231 Breast | 6879 / 30141 (22.8%) | 491 / 20477 (2.4%) | −324.0 | −324.0 | 9.52 |
| FGFR1 SRX2442438 | iPSC derived neural cells Pluripotent stem cell | 9528 / 30141 (31.6%) | 681 / 20477 (3.3%) | −324.0 | −324.0 | 9.51 |
| NELFE SRX3852891 | K-562 Blood | 13132 / 30141 (43.6%) | 939 / 20477 (4.6%) | −324.0 | −324.0 | 9.50 |
| SUPT5H SRX4385551 | HCT 116 Digestive tract | 9085 / 30141 (30.1%) | 651 / 20477 (3.2%) | −324.0 | −324.0 | 9.48 |
| BRD4 SRX17214581 | OPM-2 Blood | 4354 / 30141 (14.4%) | 312 / 20477 (1.5%) | −324.0 | −324.0 | 9.48 |
| NELFE SRX3852900 | K-562 Blood | 12111 / 30141 (40.2%) | 868 / 20477 (4.2%) | −324.0 | −324.0 | 9.48 |
| MYC SRX5307511 | P493-6 Blood | 5496 / 30141 (18.2%) | 394 / 20477 (1.9%) | −324.0 | −324.0 | 9.48 |
| NELFCD SRX10131665 | Bronchial tracheal epithelial cells Lung | 14985 / 30141 (49.7%) | 1075 / 20477 (5.2%) | −324.0 | −324.0 | 9.47 |
| ESR1 SRX2897212 | Breast cancer cells Breast | 3020 / 30141 (10.0%) | 217 / 20477 (1.1%) | −324.0 | −324.0 | 9.45 |
| HSF1 SRX13845510 | PC-3M Prostate | 3172 / 30141 (10.5%) | 228 / 20477 (1.1%) | −324.0 | −324.0 | 9.45 |
| SIN3A SRX3144857 | HUVEC Cardiovascular | 2488 / 30141 (8.3%) | 179 / 20477 (0.9%) | −324.0 | −324.0 | 9.44 |
| INTS12 SRX1711344 | Bronchial epithelial cells Lung | 8908 / 30141 (29.6%) | 641 / 20477 (3.1%) | −324.0 | −324.0 | 9.44 |
| KLF5 SRX5457562 | GM12878 Blood | 2445 / 30141 (8.1%) | 176 / 20477 (0.9%) | −324.0 | −324.0 | 9.44 |
| Epitope tags SRX14311066 | MDA-MB-231 Breast | 2292 / 30141 (7.6%) | 165 / 20477 (0.8%) | −324.0 | −324.0 | 9.44 |
| BRD2 SRX3751768 | LPS141 Adipocyte | 7958 / 30141 (26.4%) | 573 / 20477 (2.8%) | −324.0 | −324.0 | 9.44 |
| BRD4 SRX7701214 | NCI-H1963 Lung | 7944 / 30141 (26.4%) | 572 / 20477 (2.8%) | −324.0 | −324.0 | 9.44 |
| BRD4 SRX20827927 | HeLa Uterus | 3067 / 30141 (10.2%) | 221 / 20477 (1.1%) | −324.0 | −324.0 | 9.43 |
| DCP1A SRX5025678 | SH-EP Neural | 2524 / 30141 (8.4%) | 182 / 20477 (0.9%) | −324.0 | −324.0 | 9.42 |
| HSF1 SRX13845511 | PC-3M Prostate | 4174 / 30141 (13.8%) | 301 / 20477 (1.5%) | −324.0 | −324.0 | 9.42 |
| TBP SRX20387815 | HCT 116 Digestive tract | 2783 / 30141 (9.2%) | 201 / 20477 (1.0%) | −324.0 | −324.0 | 9.41 |
Showing first 500 of 23288 rows.